NFSG
DNA icon

Newbridge Financial Services Group’s Ginkgo Bioworks DNA Stock Holding History

Newbridge Financial Services Group’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-300
Closed -$4.37K – 1259
2025
Q3 		$4.37K Sell
300
-529
-64% -$6.33K ﹤0.01% 1044
2025
Q2 		$9.32K Buy
829
+529
+176% +$4.1K ﹤0.01% 909
2025
Q1 		$1.71K Hold
300
– – ﹤0.01% 905
2024
Q4 		$2.95K Hold
300
– – ﹤0.01% 929
2024
Q3 		$2.44K Hold
300
– – ﹤0.01% 547
2024
Q2 		$4.01K Sell
300
-50
-14% -$1.49K ﹤0.01% 878
2024
Q1 		$16.2K Buy
350
+300
+600% +$15.5K 0.01% 648
2023
Q4 		$3.38K Hold
50
– – ﹤0.01% 908
2023
Q3 		$3.62K Sell
50
-175
-78% -$14K ﹤0.01% 1000
2023
Q2 		$16.7K Sell
225
-25
-10% -$1.48K 0.01% 746
2023
Q1 		$13.3K Buy
250
+225
+900% +$14.3K 0.01% 850
2022
Q4 		$1.69K Hold
25
– – ﹤0.01% 1244
2022
Q3 		$3K Hold
25
– – ﹤0.01% 1124
2022
Q2 		$2K Sell
25
-69
-73% -$8.42K ﹤0.01% 1168
2022
Q1 		$15K Buy
94
+69
+276% +$13.4K 0.01% 804
2021
Q4 		$8K Sell
25
-13
-34% -$6.17K ﹤0.01% 964
2021
Q3 		$17K Buy
+38
New +$18.5K 0.01% 710

Other funds holding DNA

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Newbridge Financial Services Group's DNA Position: Q4 2025 in Review

Newbridge Financial Services Group sold out of Ginkgo Bioworks (DNA) in Q4 2025, closing a stake of 300 shares — an estimated $4.37K sold.

Newbridge Financial Services Group first reported a position in DNA in Q3 2021 and held it in 17 quarters. The position peaked at $17K in Q3 2021. 181 funds tracked by Wall St. Rank hold DNA as of Q4 2025.

  • Newbridge Financial Services Group reported no remaining Ginkgo Bioworks position as of Q4 2025 after selling out during the quarter.
  • Newbridge Financial Services Group sold 300 Ginkgo Bioworks shares in Q4 2025, an estimated $4.37K.
  • Newbridge Financial Services Group first reported a position in Ginkgo Bioworks in Q3 2021 and held it in 17 quarters.
  • Newbridge Financial Services Group's Ginkgo Bioworks position peaked at $17K in Q3 2021.
  • 181 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q4 2025.

Based on Newbridge Financial Services Group's 13F filing for Q4 2025, filed 21 Jan 2026.